NO970886L - Funksjonelle terpyridin-metallkomplekser, fremgangsmåter for fremstilling derav og oligonukleotidkonjugater med terpyridin-metallkomplekser - Google Patents

Funksjonelle terpyridin-metallkomplekser, fremgangsmåter for fremstilling derav og oligonukleotidkonjugater med terpyridin-metallkomplekser

Info

Publication number
NO970886L
NO970886L NO970886A NO970886A NO970886L NO 970886 L NO970886 L NO 970886L NO 970886 A NO970886 A NO 970886A NO 970886 A NO970886 A NO 970886A NO 970886 L NO970886 L NO 970886L
Authority
NO
Norway
Prior art keywords
terpyridine
metal complexes
pct
preparation
functional
Prior art date
Application number
NO970886A
Other languages
English (en)
Other versions
NO316866B1 (no
NO970886D0 (no
Inventor
Robert Haener
Jonathan Hall
Dieter Huesken
Uwe Pieles
Heinz Moser
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO970886D0 publication Critical patent/NO970886D0/no
Publication of NO970886L publication Critical patent/NO970886L/no
Publication of NO316866B1 publication Critical patent/NO316866B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO19970886A 1994-09-02 1997-02-27 Funksjonelle terpyridin-metallkomplekser, fremgangsmater for fremstilling derav og oligonukleotidkonjugater med terpyridin-metallkomplekser, forbindelse for anvendelse i en terapeutisk fremgangsmate, farmasoytisk preparat og anvendelse av en forbindelse t NO316866B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH269394 1994-09-02
PCT/EP1995/003409 WO1996007668A1 (de) 1994-09-02 1995-08-30 Funktionelle terpyridin-metallkomplexe, verfahren zu deren herstellung und oligonukleotid-konjugate mit terpyridin-metallkomplexen

Publications (3)

Publication Number Publication Date
NO970886D0 NO970886D0 (no) 1997-02-27
NO970886L true NO970886L (no) 1997-04-25
NO316866B1 NO316866B1 (no) 2004-06-07

Family

ID=4239459

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970886A NO316866B1 (no) 1994-09-02 1997-02-27 Funksjonelle terpyridin-metallkomplekser, fremgangsmater for fremstilling derav og oligonukleotidkonjugater med terpyridin-metallkomplekser, forbindelse for anvendelse i en terapeutisk fremgangsmate, farmasoytisk preparat og anvendelse av en forbindelse t

Country Status (15)

Country Link
US (1) US5925744A (no)
EP (1) EP0778844B1 (no)
JP (1) JPH10505354A (no)
AT (1) ATE229969T1 (no)
AU (1) AU695749B2 (no)
CA (1) CA2197788A1 (no)
CY (1) CY2435B1 (no)
DE (1) DE59510515D1 (no)
DK (1) DK0778844T3 (no)
ES (1) ES2191060T3 (no)
FI (1) FI970740A0 (no)
HU (1) HU217774B (no)
NO (1) NO316866B1 (no)
PT (1) PT778844E (no)
WO (1) WO1996007668A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2259493A1 (en) * 1996-07-03 1998-01-08 President And Fellows Of Harvard College Oligonucleotide linker and techniques involving immobilized and linked oligonucleotides
US6376664B1 (en) * 1999-03-17 2002-04-23 The Ohio State University Cyclic bis-benzimidazole ligands and metal complexes thereof
US6407089B1 (en) 1999-12-23 2002-06-18 Trinapco Inc. Triazatrinaphthyrins and the use thereof
KR100747613B1 (ko) * 1999-12-23 2007-08-09 트리나프코 인크. 트리아자트리나프티린 및 이의 용도
GB0007764D0 (en) * 2000-03-30 2000-05-17 Bp Chem Int Ltd Polymerisation catalyst
FR2810406B1 (fr) * 2000-06-15 2002-09-20 Cis Bio Int Nouveaux cryptates de terre rare peu sensibles a l'extinction de fluorescence
JP2009535383A (ja) 2006-05-03 2009-10-01 バルティック テクロノジー デヴェロプメント，リミテッド 強く結合した塩基で修飾されたオリゴヌクレオチドと人工ヌクレアーゼを組み合わせたアンチセンス作用物質
EP2285979B2 (en) 2008-05-27 2020-02-19 Dako Denmark A/S Hybridization compositions and methods
US9303287B2 (en) 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
WO2011087707A1 (en) 2009-12-22 2011-07-21 Elitech Holding B.V. Hypertheromostable endonuclease iv substrate probe
EP2761028A1 (en) 2011-09-30 2014-08-06 Dako Denmark A/S Hybridization compositions and methods using formamide
EP2768974B1 (en) 2011-10-21 2017-07-19 Dako Denmark A/S Hybridization compositions and methods
CN114315702A (zh) * 2022-02-11 2022-04-12 南京邮电大学 一种基于低维镧系金属配合物X射线激发闪烁体Eu-TPC及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
EP0266099A3 (en) * 1986-10-28 1990-09-19 The Johns Hopkins University Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids
JPH04501052A (ja) * 1988-02-26 1992-02-27 ザ・ウスター・フアウンデーシヨン・フオー・バイオメデイカル・リサーチ 外来性オリゴヌクレオチドによるｈｔｌｖ―３の抑制
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis
US5760191A (en) * 1993-02-05 1998-06-02 Nycomed Imaging As Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods

Also Published As

Publication number Publication date
FI970740A (fi) 1997-02-21
EP0778844B1 (de) 2002-12-18
NO316866B1 (no) 2004-06-07
DK0778844T3 (da) 2003-03-31
US5925744A (en) 1999-07-20
AU3474495A (en) 1996-03-27
DE59510515D1 (de) 2003-01-30
EP0778844A1 (de) 1997-06-18
AU695749B2 (en) 1998-08-20
HU217774B (hu) 2000-04-28
CY2435B1 (en) 2004-11-12
ATE229969T1 (de) 2003-01-15
JPH10505354A (ja) 1998-05-26
NO970886D0 (no) 1997-02-27
CA2197788A1 (en) 1996-03-14
FI970740A0 (fi) 1997-02-21
ES2191060T3 (es) 2003-09-01
WO1996007668A1 (de) 1996-03-14
HUT77933A (hu) 1998-11-30
PT778844E (pt) 2003-04-30

Similar Documents

Publication Publication Date Title
NO970886L (no) Funksjonelle terpyridin-metallkomplekser, fremgangsmåter for fremstilling derav og oligonukleotidkonjugater med terpyridin-metallkomplekser
GR3032355T3 (en) Cyclodextrin cellular delivery system for oligonucleotides
WO1997026270A3 (en) Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
AU603525B2 (en) Tetrazole intermediates to antihypertensive compounds
MY119800A (en) Pyridine derivatives
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
CY1109641T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια λεμφωματος
MD1838F2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
FR2689127B1 (fr) Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
HU911928D0 (en) Process for the production of chelates and its complexes containing orto ligating functional group, and the medical preparations containing thereof
DK0677116T3 (da) Fremgangsmåde til fremstilling af immunosuppressive midler og en ny mikroorganismeart til anvendelse deri
Ohnishi et al. Oxidative DNA Damage Induced by a Metabolite of 2–Naphthylamine, a Smoking‐related Bladder Carcinogen
UA72919C2 (uk) Ароматичні аміди, заміщені рибозою, спосіб їх одержання та фармацевтична композиція
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
DE60041067D1 (de) Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals
ATE116991T1 (de) Semisynthetische rhodomycine, verfahren zu ihrer herstellung und ihre verwendung als zytostatika.
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
AP2000001835A0 (en) Agents.
UA24026C2 (uk) Спосіб сиhхроhізації клітиh в g1-фазі клітиhhого циклу
DE69919386D1 (de) Zusammensetzung zur behandlung von entzündungen
MX9710501A (es) Metodo de purificacion por extraccion a partir de un medio liquido.
Oh Function and structure of ribonuclease P RNA complexed withtRNA
Sun et al. Effect of Nifedipine on Proliferation and DNA Synthesis of Human Gingival Fibroblasts
UA70975C2 (uk) Похідні 1,4-діарил-2-фтор-1-бутен-3-олу, спосіб їх одержання та способи одержання похідних 1,4-діарил-2-фтор-1,3-бутадієну і 1,4-діарил-2-фтор-2-бутену

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees